RU2017113775A - Применение нейрегулина в профилактике, лечении или отсрочке развития желудочковой аритмии и его композиция - Google Patents
Применение нейрегулина в профилактике, лечении или отсрочке развития желудочковой аритмии и его композиция Download PDFInfo
- Publication number
- RU2017113775A RU2017113775A RU2017113775A RU2017113775A RU2017113775A RU 2017113775 A RU2017113775 A RU 2017113775A RU 2017113775 A RU2017113775 A RU 2017113775A RU 2017113775 A RU2017113775 A RU 2017113775A RU 2017113775 A RU2017113775 A RU 2017113775A
- Authority
- RU
- Russia
- Prior art keywords
- nrg
- ventricular
- pharmaceutical preparation
- composition
- mammal
- Prior art date
Links
- 206010047281 Ventricular arrhythmia Diseases 0.000 title claims 12
- 239000000203 mixture Substances 0.000 title claims 6
- 230000002265 prevention Effects 0.000 title claims 2
- 102000014413 Neuregulin Human genes 0.000 title 1
- 108050003475 Neuregulin Proteins 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 10
- 208000009729 Ventricular Premature Complexes Diseases 0.000 claims 8
- 208000003663 ventricular fibrillation Diseases 0.000 claims 8
- 206010047302 ventricular tachycardia Diseases 0.000 claims 8
- 241000124008 Mammalia Species 0.000 claims 6
- 102100040896 Growth/differentiation factor 15 Human genes 0.000 claims 4
- 101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 claims 4
- 101000653754 Rattus norvegicus Sphingosine 1-phosphate receptor 5 Proteins 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 4
- ZOXZWYWOECCBSH-UHFFFAOYSA-N 4 Methyl N-ethylcathinone Chemical compound CCNC(C)C(=O)C1=CC=C(C)C=C1 ZOXZWYWOECCBSH-UHFFFAOYSA-N 0.000 claims 2
- 102400000057 Neuregulin-2 Human genes 0.000 claims 2
- 101800000675 Neuregulin-2 Proteins 0.000 claims 2
- 102400000054 Neuregulin-3 Human genes 0.000 claims 2
- 101800000673 Neuregulin-3 Proteins 0.000 claims 2
- 102400000055 Neuregulin-4 Human genes 0.000 claims 2
- 101800002641 Neuregulin-4 Proteins 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 claims 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 claims 1
- 239000003087 receptor blocking agent Substances 0.000 claims 1
- 229940125794 sodium channel blocker Drugs 0.000 claims 1
- 239000003195 sodium channel blocking agent Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410529437.4A CN105497876B (zh) | 2014-09-24 | 2014-09-24 | 神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物 |
| CN201410529437.4 | 2014-09-24 | ||
| PCT/CN2015/088972 WO2016045493A1 (zh) | 2014-09-24 | 2015-09-06 | 神经调节蛋白预防、治疗或延迟室性心律失常的用途及其组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2017113775A true RU2017113775A (ru) | 2018-10-26 |
| RU2017113775A3 RU2017113775A3 (enExample) | 2019-04-04 |
Family
ID=55580273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017113775A RU2017113775A (ru) | 2014-09-24 | 2015-09-06 | Применение нейрегулина в профилактике, лечении или отсрочке развития желудочковой аритмии и его композиция |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10441633B2 (enExample) |
| EP (1) | EP3199174B1 (enExample) |
| JP (1) | JP2017530127A (enExample) |
| KR (1) | KR20170055492A (enExample) |
| CN (2) | CN105497876B (enExample) |
| AU (1) | AU2015320230B2 (enExample) |
| CA (1) | CA2961813A1 (enExample) |
| RU (1) | RU2017113775A (enExample) |
| WO (1) | WO2016045493A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2530526T3 (es) | 2005-12-30 | 2015-03-03 | Zensun Shanghai Science And Technology Ltd | Liberación extendida de neurregulina para mejorar la función cardíaca |
| JP6096262B2 (ja) | 2009-08-25 | 2017-03-15 | ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． | ニューレグリンに基づく心不全の治療方法 |
| WO2013053076A1 (en) | 2011-10-10 | 2013-04-18 | Zensun （Shanghai）Science & Technology Limited | Compositions and methods for treating heart failure |
| AU2012392119B2 (en) | 2012-10-08 | 2018-07-26 | Zensun (Shanghai) Science & Technology, Co. Ltd. | Compositions and methods for treating heart failure in diabetic patients |
| EP3895724B1 (en) | 2013-05-22 | 2025-06-25 | Zensun (Shanghai) Science and Technology, Co., Ltd. | Extended release of neuregulin for treating heart failure |
| CN110946993A (zh) | 2014-01-03 | 2020-04-03 | 上海泽生科技开发股份有限公司 | 纽兰格林制剂的配方 |
| CN111407882A (zh) | 2014-10-17 | 2020-07-14 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物 |
| US12295930B2 (en) * | 2018-08-14 | 2025-05-13 | Emory University | Inducing proliferation of cardiomyocytes and therapeutic uses related thereto |
| AR121035A1 (es) | 2019-04-01 | 2022-04-13 | Lilly Co Eli | Compuestos de neuregulina-4 y métodos de uso |
| JP2022547335A (ja) * | 2019-09-16 | 2022-11-11 | ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． | 組換えヒトニューレグリン誘導体及びその使用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5716930A (en) | 1991-04-10 | 1998-02-10 | Ludwig Institute For Cancer Research | Glial growth factors |
| US7115554B1 (en) | 1993-05-06 | 2006-10-03 | Acorda Therapeutics, Inc. | Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| US5530109A (en) | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
| US5834229A (en) | 1991-05-24 | 1998-11-10 | Genentech, Inc. | Nucleic acids vectors and host cells encoding and expressing heregulin 2-α |
| US5912326A (en) | 1995-09-08 | 1999-06-15 | President And Fellows Of Harvard College | Cerebellum-derived growth factors |
| AU745324B2 (en) | 1997-10-14 | 2002-03-21 | Cenes Pharmaceuticals, Inc. | Therapeutic methods comprising use of a neuregulin |
| AUPP785098A0 (en) | 1998-12-21 | 1999-01-21 | Victor Chang Cardiac Research Institute, The | Treatment of heart disease |
| US6635249B1 (en) | 1999-04-23 | 2003-10-21 | Cenes Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
| CN1138785C (zh) | 1999-06-04 | 2004-02-18 | 周明东 | 生长因子神经调节蛋白及其类似物的新应用 |
| AUPQ105799A0 (en) | 1999-06-18 | 1999-07-08 | Victor Chang Cardiac Research Institute, The | Cell growth inhibition |
| CN1498656A (zh) * | 2002-11-08 | 2004-05-26 | 上海泽生科技开发有限公司 | 神经调节蛋白用于心肌梗死治疗的方法和组合物 |
| AU2002304965A1 (en) | 2002-05-24 | 2003-12-12 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
| EP1850841A1 (en) | 2005-01-20 | 2007-11-07 | Janssen Pharmaceutica N.V. | Methods for qt interval control |
| US20070213264A1 (en) | 2005-12-02 | 2007-09-13 | Mingdong Zhou | Neuregulin variants and methods of screening and using thereof |
| ES2530526T3 (es) | 2005-12-30 | 2015-03-03 | Zensun Shanghai Science And Technology Ltd | Liberación extendida de neurregulina para mejorar la función cardíaca |
| US9580515B2 (en) | 2006-08-21 | 2017-02-28 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Neukinase, a downstream protein of neuregulin |
| CN101310766B (zh) * | 2007-05-25 | 2014-04-16 | 上海泽生科技开发有限公司 | 神经调节蛋白的新用途 |
| US20090156488A1 (en) | 2007-09-12 | 2009-06-18 | Zensun (Shanghai) Science & Technology Limited | Use of neuregulin for organ preservation |
| US8603817B2 (en) * | 2008-11-03 | 2013-12-10 | University Of Washington | Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signaling |
| EP2370093A4 (en) | 2008-11-28 | 2012-08-29 | Zensun Shanghai Science And Technology Ltd | NEUREGULIN AND CARDIAC STEM CELLS |
| EP2370458B1 (en) | 2008-11-28 | 2014-10-15 | Zensun (Shanghai) Science and Technology Limited | Neuregulin peptides and their use |
| ES2748886T3 (es) | 2009-06-09 | 2020-03-18 | Zensun Shanghai Science & Tech Co Ltd | Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca |
| ES2575125T3 (es) | 2009-06-09 | 2016-06-24 | Zensun (Shanghai) Science And Technology Limited | Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca |
| CN102139095A (zh) | 2010-01-29 | 2011-08-03 | 上海泽生科技开发有限公司 | 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物 |
| WO2011119836A1 (en) * | 2010-03-24 | 2011-09-29 | Massachusetts Institute Of Technology | Methods and compositions for cardioprotection and cardioregeneration |
| US20120028992A1 (en) * | 2010-08-02 | 2012-02-02 | Brown Arthur M | Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals |
| WO2012054718A2 (en) | 2010-10-22 | 2012-04-26 | The General Hospital Corporation | Treating long qt syndrome |
| CN102302552A (zh) * | 2011-08-31 | 2012-01-04 | 朱明军 | 一种治疗心律失常的胶囊及其制备方法 |
| WO2013053076A1 (en) | 2011-10-10 | 2013-04-18 | Zensun （Shanghai）Science & Technology Limited | Compositions and methods for treating heart failure |
| AU2012392119B2 (en) | 2012-10-08 | 2018-07-26 | Zensun (Shanghai) Science & Technology, Co. Ltd. | Compositions and methods for treating heart failure in diabetic patients |
| EP3895724B1 (en) | 2013-05-22 | 2025-06-25 | Zensun (Shanghai) Science and Technology, Co., Ltd. | Extended release of neuregulin for treating heart failure |
| EP3027190A1 (en) | 2013-08-01 | 2016-06-08 | Gilead Sciences, Inc. | Compound and methods for treating long qt syndrome |
| CN104758300A (zh) | 2014-01-02 | 2015-07-08 | 上海泽生科技开发有限公司 | 维生素d及其组合物的抗菌用途 |
| CN110946993A (zh) | 2014-01-03 | 2020-04-03 | 上海泽生科技开发股份有限公司 | 纽兰格林制剂的配方 |
| CN111407882A (zh) | 2014-10-17 | 2020-07-14 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物 |
-
2014
- 2014-09-24 CN CN201410529437.4A patent/CN105497876B/zh active Active
-
2015
- 2015-09-06 CA CA2961813A patent/CA2961813A1/en not_active Abandoned
- 2015-09-06 KR KR1020177008203A patent/KR20170055492A/ko not_active Withdrawn
- 2015-09-06 RU RU2017113775A patent/RU2017113775A/ru not_active Application Discontinuation
- 2015-09-06 WO PCT/CN2015/088972 patent/WO2016045493A1/zh not_active Ceased
- 2015-09-06 EP EP15845381.1A patent/EP3199174B1/en not_active Revoked
- 2015-09-06 CN CN201580050316.4A patent/CN110337304A/zh active Pending
- 2015-09-06 AU AU2015320230A patent/AU2015320230B2/en active Active
- 2015-09-06 JP JP2017516166A patent/JP2017530127A/ja active Pending
- 2015-09-06 US US15/513,939 patent/US10441633B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015320230B2 (en) | 2021-06-24 |
| WO2016045493A1 (zh) | 2016-03-31 |
| CN105497876B (zh) | 2021-01-15 |
| US20170368140A1 (en) | 2017-12-28 |
| AU2015320230A1 (en) | 2017-03-30 |
| US10441633B2 (en) | 2019-10-15 |
| JP2017530127A (ja) | 2017-10-12 |
| EP3199174B1 (en) | 2022-04-13 |
| CA2961813A1 (en) | 2016-03-31 |
| CN110337304A (zh) | 2019-10-15 |
| RU2017113775A3 (enExample) | 2019-04-04 |
| EP3199174A4 (en) | 2018-06-06 |
| EP3199174A1 (en) | 2017-08-02 |
| CN105497876A (zh) | 2016-04-20 |
| KR20170055492A (ko) | 2017-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017113775A (ru) | Применение нейрегулина в профилактике, лечении или отсрочке развития желудочковой аритмии и его композиция | |
| RU2017116973A (ru) | Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса | |
| EA202092003A1 (ru) | Соединения для лечения болезни гентингтона | |
| JP2017532343A5 (enExample) | ||
| EA201800367A1 (ru) | Способы лечения болезни хантингтона | |
| MX2023003875A (es) | Formulacion de una vacuna peptidica. | |
| UY38986A (es) | Compuestos derivados de 3-(5-metoxi-1-oxoisoindolin-2-il) piperidin-2,6-diona, métodos de usos de los mismos y combinaciones farmacéuticas | |
| EP4559481A3 (en) | Methods of treatment of cholestatic diseases | |
| EP4616914A3 (en) | Polypeptides binding to human complement c5 | |
| WO2016070166A3 (en) | Messenger una molecules and uses thereof | |
| EA201891399A1 (ru) | Бипиразолильные производные, пригодные для лечения аутоиммунных заболеваний | |
| EA201791535A1 (ru) | Новое соединение 4'-тионуклеозида, а также способ его получения, его фармацевтическая композиция и применение | |
| WO2016014533A3 (en) | Devices and methods for fixation of animal tissue | |
| EA202091482A1 (ru) | Антитела | |
| CL2017003097A1 (es) | Composiciones y métodos para el tratamiento de la enfermedad celiaca | |
| WO2017136731A8 (en) | Rapaglutins, novel inhibitors of glut and use thereof | |
| EP3932418A3 (en) | Peptides for use in promoting transport of glucose | |
| WO2016020880A3 (en) | Angiopoietin-like 4 antibodies and methods of use | |
| WO2016133152A3 (ja) | 蛋白質吸着抑制方法 | |
| EP3922264A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF SKIN DISEASES | |
| WO2017103094A3 (en) | Means and methods for treating copper-related diseases | |
| MX2020010807A (es) | Peptidos promotores del crecimiento y usos de los mismos. | |
| WO2019016597A3 (en) | SYNTHETIC PROTEINS AND THEIR THERAPEUTIC USES | |
| WO2018069831A3 (en) | Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors | |
| TW201613977A (en) | Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant | ||
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20200730 |